Previous studies have revealed that CXCR2 and its ligands (CXCL-1, −2, −3, −5, −6, −7, and −8) are involved in tumor angiogenesis, tumorigenesis, and metastasis of several types of human cancers, such as colorectal carcinoma, melanoma, lung cancer, renal cell carcinoma, prostate carcinoma, pancreatic carcinoma, and esophageal carcinoma [15–21]. Here, CXCL1 is linked to neoplasm.